Form CORRESP - Correspondence:
SEC Accession No. 0001641172-25-003405
Filing Date
2025-04-09
Accepted
2025-04-09 16:07:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11441
  Complete submission text file 0001641172-25-003405.txt   12474
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)